These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31934598)

  • 1. Genetic Engineering of T Cells for Immune Tolerance.
    Scott DW
    Mol Ther Methods Clin Dev; 2020 Mar; 16():103-107. PubMed ID: 31934598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From IgG Fusion Proteins to Engineered-Specific Human Regulatory T Cells: A Life of Tolerance.
    Scott DW
    Front Immunol; 2017; 8():1576. PubMed ID: 29181011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
    Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
    Front Immunol; 2018; 9():2359. PubMed ID: 30369931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Tregs Made Antigen Specific by Gene Modification: The Power to Treat Autoimmunity and Antidrug Antibodies with Precision.
    Adair PR; Kim YC; Zhang AH; Yoon J; Scott DW
    Front Immunol; 2017; 8():1117. PubMed ID: 28983300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy With Regulatory T Cells: A Beneficial Alliance.
    Biswas M; Kumar SRP; Terhorst C; Herzog RW
    Front Immunol; 2018; 9():554. PubMed ID: 29616042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.
    Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C
    Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific regulatory T cells: are police CARs the answer?
    Dawson NAJ; Levings MK
    Transl Res; 2017 Sep; 187():53-58. PubMed ID: 28688236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
    Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
    J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-regulatory T cells.
    Andersen MH
    Semin Immunopathol; 2017 Apr; 39(3):317-326. PubMed ID: 27677755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology.
    Koristka S; Kegler A; Bergmann R; Arndt C; Feldmann A; Albert S; Cartellieri M; Ehninger A; Ehninger G; Middeke JM; Bornhäuser M; Schmitz M; Pietzsch J; Akgün K; Ziemssen T; Steinbach J; Bachmann MP
    J Autoimmun; 2018 Jun; 90():116-131. PubMed ID: 29503042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
    Yamazaki S; Inaba K; Tarbell KV; Steinman RM
    Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T cells: a review.
    Dasgupta A; Saxena R
    Natl Med J India; 2012; 25(6):341-51. PubMed ID: 23998865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role and mechanisms of CD4+CD25+ regulatory T cells in the induction and maintenance of transplantation tolerance.
    Yong Z; Chang L; Mei YX; Yi L
    Transpl Immunol; 2007 Feb; 17(2):120-9. PubMed ID: 17306743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of human islet-specific regulatory T cells by TCR gene transfer.
    Hull CM; Nickolay LE; Estorninho M; Richardson MW; Riley JL; Peakman M; Maher J; Tree TI
    J Autoimmun; 2017 May; 79():63-73. PubMed ID: 28117148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
    Tenspolde M; Zimmermann K; Weber LC; Hapke M; Lieber M; Dywicki J; Frenzel A; Hust M; Galla M; Buitrago-Molina LE; Manns MP; Jaeckel E; Hardtke-Wolenski M
    J Autoimmun; 2019 Sep; 103():102289. PubMed ID: 31176558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
    Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
    Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemophilia A inhibitor treatment: the promise of engineered T-cell therapy.
    Parvathaneni K; Abdeladhim M; Pratt KP; Scott DW
    Transl Res; 2017 Sep; 187():44-52. PubMed ID: 28651073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avidity and Bystander Suppressive Capacity of Human Regulatory T Cells Expressing
    Yeh WI; Seay HR; Newby B; Posgai AL; Moniz FB; Michels A; Mathews CE; Bluestone JA; Brusko TM
    Front Immunol; 2017; 8():1313. PubMed ID: 29123516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from
    Nowak A; Lock D; Bacher P; Hohnstein T; Vogt K; Gottfreund J; Giehr P; Polansky JK; Sawitzki B; Kaiser A; Walter J; Scheffold A
    Front Immunol; 2018; 9():199. PubMed ID: 29467769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ＜Editors' Choice＞ Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity.
    Kochin V; Nishikawa H
    Nagoya J Med Sci; 2019 Feb; 81(1):1-18. PubMed ID: 30962651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.